Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
2.

Advanced pancreatic cancer clinical trials: The continued underrepresentation of older patients.

White MN, Dotan E, Catalano PJ, Cardin DB, Berlin JD.

J Geriatr Oncol. 2018 Dec 17. pii: S1879-4068(18)30145-0. doi: 10.1016/j.jgo.2018.11.001. [Epub ahead of print] Review.

PMID:
30573201
3.

Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial.

Cardin DB, Goff LW, Chan E, Whisenant JG, Dan Ayers G, Takebe N, Arlinghaus LR, Yankeelov TE, Berlin J, Merchant N.

Invest New Drugs. 2018 Jun;36(3):442-450. doi: 10.1007/s10637-017-0519-z. Epub 2017 Oct 9.

PMID:
28990119
4.

Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?

Thota R, Gonzalez RS, Berlin J, Cardin DB, Shi C.

Am J Clin Pathol. 2017 Sep 1;148(3):208-214. doi: 10.1093/AJCP/AQX070.

PMID:
28821192
5.

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB 3rd, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, Ferrone CR, Hardacre J, Hawkins WG, Herman J, Ko AH, Komanduri S, Koong A, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Scaife C, Thayer S, Weekes CD, Wolff RA, Wolpin BM, Burns J, Darlow S.

J Natl Compr Canc Netw. 2017 Aug;15(8):1028-1061. doi: 10.6004/jnccn.2017.0131.

PMID:
28784865
6.

Phase II study of the Multikinase inhibitor of angiogenesis, Linifanib, in patients with metastatic and refractory colorectal cancer expressing mutated KRAS.

Chan E, Goff LW, Cardin DB, Ancell K, Smith SJ, Whisenant JG, Ye F, Berlin JD.

Invest New Drugs. 2017 Aug;35(4):491-498. doi: 10.1007/s10637-017-0458-8. Epub 2017 Mar 28.

PMID:
28353122
7.

A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer.

Cardin DB, Thota R, Goff LW, Berlin JD, Jones CM, Ayers GD, Whisenant JG, Chan E.

Am J Clin Oncol. 2018 Aug;41(8):772-776. doi: 10.1097/COC.0000000000000377.

PMID:
28301350
8.

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers.

Goff LW, Cardin DB, Whisenant JG, Du L, Koyama T, Dahlman KB, Salaria SN, Young RT, Ciombor KK, Gilbert J, Smith SJ, Chan E, Berlin J.

Invest New Drugs. 2017 Feb;35(1):95-104. doi: 10.1007/s10637-016-0406-z. Epub 2016 Nov 16.

9.

Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer.

Chan E, Arlinghaus LR, Cardin DB, Goff L, Berlin JD, Parikh A, Abramson RG, Yankeelov TE, Hiebert S, Merchant N, Bhaskara S, Chakravarthy AB.

Radiother Oncol. 2016 May;119(2):312-8. doi: 10.1016/j.radonc.2016.04.013. Epub 2016 Apr 19.

10.

Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers.

Goff LW, Thakkar N, Du L, Chan E, Tan BR, Cardin DB, McLeod HL, Berlin JD, Zehnbauer B, Fournier C, Picus J, Wang-Gillam A, Lee W, Lockhart AC.

PLoS One. 2014 Sep 18;9(9):e107424. doi: 10.1371/journal.pone.0107424. eCollection 2014.

11.

Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer.

Cardin DB, Goff L, Li CI, Shyr Y, Winkler C, DeVore R, Schlabach L, Holloway M, McClanahan P, Meyer K, Grigorieva J, Berlin J, Chan E.

Cancer Med. 2014 Jun;3(3):572-9. doi: 10.1002/cam4.208. Epub 2014 Feb 12.

12.

Pancreas cancer on the rise: are we up to the challenge?

Cardin DB, Berlin JD.

J Natl Cancer Inst. 2013 Nov 20;105(22):1675-6. doi: 10.1093/jnci/djt316. Epub 2013 Nov 7. No abstract available.

PMID:
24203986
13.

Treatment of early-stage pancreatic cancer.

Castellanos EH, Cardin DB, Berlin JD.

Oncology (Williston Park). 2011 Feb;25(2):182-9. Review.

Supplemental Content

Loading ...
Support Center